comparemela.com

Latest Breaking News On - Essa pharma inc - Page 8 : comparemela.com

ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesComunidad autonoma de catalunaBritish columbiaNan hyung hongPharma incAsed chimeraMolecular targetsCancer therapeuticsProstate cancerNew drugsPrivate securities litigation reform actEssa pharma incHealth care amp hospitalsMedical pharmaceuticals

ESSA Pharma Appoints Philip Kantoff to its Board of Directors

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesBritish columbiaRichardm glickmanPhilip kantoffNancy kohlbergHarvard medical schoolProfessor of medicine at harvard medical schoolDivision head of solid tumor oncologyLank centerDana farber cancer instituteBrown universityPharma incChief executive officerConvergent therapeuticsMemorial sloan kettering cancer centerNancy kohlberg chair

ESSA Pharma to Present at 2022 Jefferies Healthcare Conference

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesBritish columbiaDavids woodPharma incHealthcare conferenceNew york cityChief executive officerFinancial officerEssa pharma inc

ESSA Pharma to Present at the 2022 Bloom Burton & Co Healthcare Investor Conference

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesBritish columbiaDavids woodPeter virsikMetro toronto convention centreBloom burton coPharma incHealthcare investor conferenceChief executive officerOperating officerFinancial officerBloom burtonHealthcare investorEssa pharma inc

ESSA Pharma Announces the Presentation of Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesBritish columbiaNan hyung hongOrleans convention centerAmerican association for cancer researchAmerican association for cancer research annual meetingPharma incCancer research annualAsed chimeraCancer researchChief executive officerN terminal domainProtein degradersNew orleans convention centerExhibit hallsd hPoster section

vimarsana © 2020. All Rights Reserved.